Works by Hirooka, Masashi


Results: 185
    1
    2

    Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

    Published in:
    Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192
    By:
    • Hatanaka, Takeshi;
    • Yata, Yutaka;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Kakizaki, Satoru;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Koshiyama, Yuichi;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi
    Publication type:
    Article
    3

    Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/ CT.

    Published in:
    Liver International, 2013, v. 33, n. 7, p. 1085, doi. 10.1111/liv.12161
    By:
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Ochi, Hironori;
    • Koizumi, Yohei;
    • Shimizu, Yuko;
    • Shiraishi, Akiko;
    • Yamago, Hiroka;
    • Tanihira, Tetsuya;
    • Miyata, Hideki;
    • Ninomiya, Tomoyuki;
    • Kawasaki, Hideki;
    • Ishimaru, Yoshihiro;
    • Sogabe, Ichiro;
    • Inoue, Takeshi;
    • Abe, Masanori;
    • Hiasa, Yoichi;
    • Matsuura, Bunzo;
    • Onji, Morikazu;
    • Michitaka, Kojiro
    Publication type:
    Article
    4
    5

    Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation.

    Published in:
    Oncology, 2024, v. 102, n. 4, p. 291, doi. 10.1159/000533672
    By:
    • Hiraoka, Atsushi;
    • Tada, Fujimasa;
    • Ohama, Hideko;
    • Fukumoto, Mai;
    • Matsuoka, Kana;
    • Matsuda, Takuya;
    • Nakatani, Kosuke;
    • Yanagihara, Emi;
    • Saneto, Hironobu;
    • Izumoto, Hirofumi;
    • Murakami, Taisei;
    • Onishi, Kei;
    • Kitahata, Shogo;
    • Kanemitsu-Okada, Kozue;
    • Kawamura, Tomoe;
    • Kuroda, Taira;
    • Miyata, Hideki;
    • Tsubouchi, Eiji;
    • Hirooka, Masashi;
    • Abe, Masanori
    Publication type:
    Article
    6

    Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

    Published in:
    Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    7

    Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.

    Published in:
    Oncology, 2023, v. 101, n. 9, p. 575, doi. 10.1159/000530987
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Fujimasa;
    • Kato, Kanako;
    • Fukunishi, Yoshiko;
    • Yanagihara, Emi;
    • Kato, Masaya;
    • Saneto, Hironobu;
    • Izumoto, Hirofumi;
    • Ueki, Hidetaro;
    • Yoshino, Takeaki;
    • Kitahata, Shogo;
    • Kawamura, Tomoe;
    • Kuroda, Taira;
    • Suga, Yoshifumi;
    • Miyata, Hideki;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Matsuura, Bunzo;
    • Ninomiya, Tomoyuki
    Publication type:
    Article
    8

    Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

    Published in:
    Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    9

    Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

    Published in:
    Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Hirooka, Masashi;
    • Takaguchi, Koichi;
    • Atsukawa, Masanori;
    • Fukunishi, Shinya;
    • Itobayashi, Ei;
    • Tsuji, Kunihiko;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Ishikawa, Toru;
    • Yasuda, Satoshi;
    • Ogawa, Chikara;
    • Toyoda, Hidenori;
    • Hatanaka, Takeshi;
    • Nishimura, Takashi;
    • Kakizaki, Satoru
    Publication type:
    Article
    10

    Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    11

    Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Kawata, Kazuhito
    Publication type:
    Article
    12

    Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Toyoda, Hidenori;
    • Ohama, Hideko;
    • Tsutsui, Akemi;
    • Itokawa, Norio
    Publication type:
    Article
    13

    Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    14

    Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    15

    Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.

    Published in:
    Oncology, 2019, v. 96, n. 5, p. 242, doi. 10.1159/000496225
    By:
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Ochi, Hironori;
    • Koizumi, Yohei;
    • Izumoto, Hirofumi;
    • Ueki, Hidetaro;
    • Tsuruta, Miho;
    • Ono, Atsushi;
    • Yoshino, Takeaki;
    • Aibiki, Toshihiko;
    • Okudaira, Tomonari;
    • Yamago, Hiroka;
    • Suga, Yoshifumi;
    • Iwasaki, Ryuichiro;
    • Mori, Kenichiro;
    • Miyata, Hideki;
    • Kishida, Masato;
    • Tsubouchi, Eiji;
    • Abe, Masanori;
    • Matsuura, Bunzo
    Publication type:
    Article
    16

    Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.

    Published in:
    Oncology, 2017, v. 93, p. 120, doi. 10.1159/000481242
    By:
    • Izumoto, Hirofumi;
    • Hiraoka, atsushi;
    • Ishimaru, Yoshihiro;
    • Murakami, Tadashi;
    • Kitahata, Shogo;
    • Ueki, Hidetaro;
    • aibiki, Toshihiko;
    • Okudaira, Tomonari;
    • Miyamoto, Yuji;
    • Yamago, Hiroka;
    • Iwasaki, Ryuichiro;
    • Tomida, Hideomi;
    • Mori, Kenichiro;
    • Kishida, Masato;
    • Tsubouchi, Eiji;
    • Miyata, Hideki;
    • Ninomiya, Tomoyuki;
    • Kawasaki, Hideki;
    • Hirooka, Masashi;
    • Matsuura, Bunzo
    Publication type:
    Article
    17
    18

    Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.

    Published in:
    Oncology, 2015, v. 89, n. 3, p. 167, doi. 10.1159/000381808
    By:
    • Hiraoka, Atsushi;
    • Ishimaru, Yoshihiro;
    • Kawasaki, Hideki;
    • Aibiki, Toshihiko;
    • Okudaira, Tomonari;
    • Toshimori, Akiko;
    • Kawamura, Tomoe;
    • Yamago, Hiroka;
    • Nakahara, Hiromasa;
    • Suga, Yoshifumi;
    • Azemoto, Nobuaki;
    • Miyata, Hideki;
    • Miyamoto, Yasunao;
    • Ninomiya, Tomoyuki;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Matsuura, Bunzo;
    • Hiasa, Yoichi;
    • Michitaka, Kojiro
    Publication type:
    Article
    19

    Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.

    Published in:
    Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74
    By:
    • Nouso, Kazuhiro;
    • Shiota, Shohei;
    • Fujita, Rio;
    • Wakuta, Akiko;
    • Kariyama, Kazuya;
    • Hiraoka, Atsushi;
    • Atsukawa, Masanori;
    • Tani, Joji;
    • Tada, Toshifumi;
    • Matsuo, Yu;
    • Nakamura, Shinichiro;
    • Tajiri, Kazuto;
    • Kaibori, Masaki;
    • Hirooka, Masashi;
    • Itobayashi, Ei;
    • Kakizaki, Satoru;
    • Naganuma, Atsushi;
    • Ishikawa, Toru;
    • Hatanaka, Takeshi;
    • Fukunishi, Shinya
    Publication type:
    Article
    20

    Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    21

    What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
    By:
    • Atsushi Hiraoka;
    • Takashi Kumada;
    • Toshifumi Tada;
    • Kazuya Kariyama;
    • Joji Tani;
    • Shinya Fukunishi;
    • Masanori Atsukawa;
    • Masashi Hirooka;
    • Kunihiko Tsuji;
    • Toru Ishikawa;
    • Koichi Takaguchi;
    • Ei Itobayashi;
    • Kazuto Tajiri;
    • Noritomo Shimada;
    • Hiroshi Shibata;
    • Hironori Ochi;
    • Kazuhito Kawata;
    • Satoshi Yasuda;
    • Hidenori Toyoda;
    • Hideko Ohama
    Publication type:
    Article
    22

    Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Yokohama, Keisuke;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya
    Publication type:
    Article
    23
    24

    Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
    By:
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi;
    • Kawata, Kazuhito;
    • Kosaka, Hisashi
    Publication type:
    Article
    25

    Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Nishikawa, Hiroki;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Koshiyama, Yuichi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Kawata, Kazuhito
    Publication type:
    Article
    26
    27
    28

    Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis.

    Published in:
    Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102540
    By:
    • Miyake, Teruki;
    • Furukawa, Shinya;
    • Matsuura, Bunzo;
    • Yoshida, Osamu;
    • Miyazaki, Masumi;
    • Shiomi, Akihito;
    • Kanzaki, Sayaka;
    • Nakaguchi, Hironobu;
    • Sunago, Kotaro;
    • Nakamura, Yoshiko;
    • Imai, Yusuke;
    • Watanabe, Takao;
    • Yamamoto, Yasunori;
    • Koizumi, Yohei;
    • Tokumoto, Yoshio;
    • Hirooka, Masashi;
    • Kumagi, Teru;
    • Abe, Masanori;
    • Hiasa, Yoichi
    Publication type:
    Article
    29

    Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 11, p. 3584, doi. 10.1002/cam4.3908
    By:
    • Hiraoka, Atsushi;
    • Kato, Masaya;
    • Marui, Kaori;
    • Murakami, Taisei;
    • Onishi, Kei;
    • Adachi, Tomoko;
    • Matsuoka, Junko;
    • Ueki, Hidetaro;
    • Yoshino, Takeaki;
    • Tsuruta, Miho;
    • Aibiki, Toshihiko;
    • Okudaira, Tomonari;
    • Kuroda, Taira;
    • Iwasaki, Ryuichiro;
    • Suga, Yoshifumi;
    • Miyata, Hideki;
    • Ninomiya, Tomoyuki;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Matsuura, Bunzo
    Publication type:
    Article
    30

    Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    31

    Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Kariyama, Kazuya;
    • Takaguchi, Koichi;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Tsuji, Kunihiko;
    • Tajiri, Kazuto;
    • Hirooka, Masashi;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ishikawa, Toru;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Itokawa, Norio;
    • Imai, Michitaka;
    • Joko, Kouji
    Publication type:
    Article
    32

    Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    33

    PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.

    Published in:
    Scientific Reports, 2024, v. 12, n. 1, p. 1, doi. 10.1038/s41598-024-75142-5
    By:
    • Okujima, Yusuke;
    • Watanabe, Takao;
    • Ito, Takeshi;
    • Inoue, Yasumichi;
    • Kasai, Yutaka;
    • Imai, Yusuke;
    • Nakamura, Yoshiko;
    • Koizumi, Mitsuhito;
    • Yoshida, Osamu;
    • Tokumoto, Yoshio;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Kawakami, Ryosuke;
    • Saitou, Takashi;
    • Imamura, Takeshi;
    • Murakami, Yoshinori;
    • Hiasa, Yoichi
    Publication type:
    Article
    34

    PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-75142-5
    By:
    • Okujima, Yusuke;
    • Watanabe, Takao;
    • Ito, Takeshi;
    • Inoue, Yasumichi;
    • Kasai, Yutaka;
    • Imai, Yusuke;
    • Nakamura, Yoshiko;
    • Koizumi, Mitsuhito;
    • Yoshida, Osamu;
    • Tokumoto, Yoshio;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Kawakami, Ryosuke;
    • Saitou, Takashi;
    • Imamura, Takeshi;
    • Murakami, Yoshinori;
    • Hiasa, Yoichi
    Publication type:
    Article
    35

    Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306).

    Published in:
    Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 105, doi. 10.3350/cmh.2024.0198
    By:
    • Chuan Liu;
    • Hong You;
    • Qing-Lei Zeng;
    • Yu Jun Wong;
    • Bingqiong Wang;
    • Grgurevic, Ivica;
    • Chenghai Liu;
    • Hyung Joon Yim;
    • Wei Gou;
    • Bingtian Dong;
    • Shenghong Ju;
    • Yanan Guo;
    • Qian Yu;
    • Masashi Hirooka;
    • Hirayuki Enomoto;
    • Amr Shaaban Hanafy;
    • Zhujun Cao;
    • Xiemin Dong;
    • Jing LV;
    • Tae Hyung Kim
    Publication type:
    Article
    36

    Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 3, p. 440, doi. 10.4093/dmj.2023.0200
    By:
    • Teruki Miyake;
    • Shinya Furukawa;
    • Bunzo Matsuura;
    • Osamu Yoshida;
    • Masumi Miyazaki;
    • Akihito Shiomi;
    • Ayumi Kanamoto;
    • Hironobu Nakaguchi;
    • Yoshiko Nakamura;
    • Yusuke Imai;
    • Mitsuhito Koizumi;
    • Takao Watanabe;
    • Yasunori Yamamoto;
    • Yohei Koizumi;
    • Yoshio Tokumoto;
    • Masashi Hirooka;
    • Teru Kumagi;
    • Eiji Takesita;
    • Yoshio Ikeda;
    • Masanori Abe
    Publication type:
    Article
    37

    Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus.

    Published in:
    Journal of Diabetes Investigation, 2022, v. 13, n. 9, p. 1577, doi. 10.1111/jdi.13812
    By:
    • Todo, Yasuhiko;
    • Miyake, Teruki;
    • Furukawa, Shinya;
    • Matsuura, Bunzo;
    • Ishihara, Toru;
    • Miyazaki, Masumi;
    • Shiomi, Akihito;
    • Nakaguchi, Hironobu;
    • Kanzaki, Sayaka;
    • Yamamoto, Yasunori;
    • Koizumi, Yohei;
    • Yoshida, Osamu;
    • Tokumoto, Yoshio;
    • Hirooka, Masashi;
    • Takeshita, Eiji;
    • Kumagi, Teru;
    • Ikeda, Yoshio;
    • Abe, Masanori;
    • Iwata, Takeru;
    • Hiasa, Yoichi
    Publication type:
    Article
    38

    Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus.

    Published in:
    Journal of Diabetes Investigation, 2022, v. 13, n. 7, p. 1245, doi. 10.1111/jdi.13772
    By:
    • Miyake, Teruki;
    • Matsuura, Bunzo;
    • Furukawa, Shinya;
    • Ishihara, Toru;
    • Yoshida, Osamu;
    • Miyazaki, Masumi;
    • Watanebe, Kyoko;
    • Shiomi, Akihito;
    • Nakaguchi, Hironobu;
    • Yamamoto, Yasunori;
    • Koizumi, Yohei;
    • Tokumoto, Yoshio;
    • Hirooka, Masashi;
    • Takeshita, Eiji;
    • Kumagi, Teru;
    • Abe, Masanori;
    • Ikeda, Yoshio;
    • Iwata, Takeru;
    • Hiasa, Yoichi
    Publication type:
    Article
    39

    Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.

    Published in:
    Journal of Diabetes Investigation, 2021, v. 12, n. 10, p. 1890, doi. 10.1111/jdi.13548
    By:
    • Miyake, Teruki;
    • Matsuura, Bunzo;
    • Furukawa, Shinya;
    • Yoshida, Osamu;
    • Hirooka, Masashi;
    • Kumagi, Teru;
    • Ishihara, Toru;
    • Kanzaki, Sayaka;
    • Nakaguchi, Hironobu;
    • Miyazaki, Masumi;
    • Nakamura, Yoshiko;
    • Yamamoto, Yasunori;
    • Koizumi, Yohei;
    • Tokumoto, Yoshio;
    • Takeshita, Eiji;
    • Ikeda, Yoshio;
    • Abe, Masanori;
    • Kitai, Kohichiro;
    • Hiasa, Yoichi
    Publication type:
    Article
    40

    Relationship between urine pH and abnormal glucose tolerance in a community‐based study.

    Published in:
    Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 769, doi. 10.1111/jdi.12777
    By:
    • Yoshida, Sakiko;
    • Miyake, Teruki;
    • Yamamoto, Shin;
    • Furukawa, Shinya;
    • Niiya, Tetsuji;
    • Senba, Hidenori;
    • Kanzaki, Sayaka;
    • Yoshida, Osamu;
    • Ishihara, Toru;
    • Koizumi, Mitsuhito;
    • Hirooka, Masashi;
    • Kumagi, Teru;
    • Abe, Masanori;
    • Kitai, Kohichiro;
    • Matsuura, Bunzo;
    • Hiasa, Yoichi
    Publication type:
    Article
    41
    42
    43
    44
    45

    Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

    Published in:
    Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563
    By:
    • Toyoda, Hidenori;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Michitaka, Kojiro;
    • Takaguchi, Koichi;
    • Tsuji, Kunihiko;
    • Itobayashi, Ei;
    • Takizawa, Daichi;
    • Hirooka, Masashi;
    • Koizumi, Yohei;
    • Ochi, Hironori;
    • Joko, Koji;
    • Kisaka, Yoshiyasu;
    • Shimizu, Yuko;
    • Tajiri, Kazuto;
    • Tani, Joji;
    • Taniguchi, Tatsuya;
    • Toshimori, Akiko;
    • Fujioka, Shinichi;
    • Kumada, Takashi
    Publication type:
    Article
    46
    47
    48

    Simple method for predicting muscle volume loss using geriatric nutritional risk index in hepatocellular carcinoma patients.

    Published in:
    Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 4, p. 1906, doi. 10.1002/jcsm.13268
    By:
    • Hiraoka, Atsushi;
    • Ohama, Hideko;
    • Tada, Fujimasa;
    • Fukunishi, Yoshiko;
    • Yanagihara, Emi;
    • Kato, Kanako;
    • Kato, Masaya;
    • Saneto, Hironobu;
    • Izumoto, Hirofumi;
    • Ueki, Hidetaro;
    • Yoshino, Takeaki;
    • Kitahata, Shogo;
    • Kawamura, Tomoe;
    • Kuroda, Taira;
    • Suga, Yoshifumi;
    • Miyata, Hideki;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Matsuura, Bunzo;
    • Ninomiya, Tomoyuki
    Publication type:
    Article
    49

    Easy surveillance of muscle volume decline in chronic liver disease patients using finger‐circle (yubi‐wakka) test.

    Published in:
    Journal of Cachexia, Sarcopenia & Muscle, 2019, v. 10, n. 2, p. 347, doi. 10.1002/jcsm.12392
    By:
    • Hiraoka, Atsushi;
    • Izumoto, Hirofumi;
    • Ueki, Hidetaro;
    • Yoshino, Takeaki;
    • Aibiki, Toshihiko;
    • Okudaira, Tomonari;
    • Yamago, Hiroka;
    • Suga, Yoshifumi;
    • Iwasaki, Ryuichiro;
    • Tomida, Hideomi;
    • Mori, Kenichiro;
    • Miyata, Hideki;
    • Tsubouchi, Eiji;
    • Kishida, Masato;
    • Ninomiya, Tomoyuki;
    • Hirooka, Masashi;
    • Abe, Masanori;
    • Matsuura, Bunzo;
    • Hiasa, Yoichi;
    • Michitaka, Kojiro
    Publication type:
    Article
    50